Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Methuselah Medical Technology

Request full access

Specializes in the design, development and manufacture of robust, rugged, and user-friendly volumetric intravenous

ChinaFounded 2012Health Tech & Medtech

About Methuselah Medical Technology

Methuselah (Shanghai) Medical Technology Co., Ltd. is a medical nutrition company established in March 2012, operating from the International Medical Park in Shanghai, a hub for high-tech pharmaceutical enterprises. The firm integrates research and development, production, and sales, focusing on the specific nutritional needs of the Chinese population. To enhance its R&D capabilities, the company has formed a strategic alliance with a major U.S. medical food technology company and collaborates with various domestic clinical nutrition expert teams. It has also established academic partnerships with prominent institutions like the Chinese Nutrition Society and the Chinese Medical Association.

The company's business model is centered on developing and selling medical nutrition products directly to healthcare providers and patients, with its products being used in over 300 top-tier hospitals in China. Methuselah Medical Technology's product portfolio is organized into four main categories. The first is a line of special medical formula foods, featuring products named Youkangli and Youyili. The second category consists of nutritionally fortified foods such as Yusu and Yusu Peptide. A third series focuses on low-glycemic index (Low-GI) foods, including biscuits, noodles, and meal replacement powders. The final category includes energy-controlled and fat-controlled food series. The company operates two production bases, including one in Luohe, Henan, which specializes in low-GI foods.

Methuselah's establishment coincided with a significant shift in China's regulatory landscape for medical foods, positioning the company to capitalize on the growing market for special medical purpose formula foods. The company's name itself, referencing the biblical figure who lived for 969 years, reflects its mission to promote health and longevity through medical nutrition. Internally, Methuselah has assembled a professional R&D team comprising dozens of experts with titles as physicians, pharmacists, and nutritionists, which it considers a core component of its competitive strength.

Source: Dealroom company data

At a glance

Status
Operational
Employees
12
Open positions
1
Dealroom signal
46.8/100
Industry
Health
Sub-industry
Medical Devices
Sector
Chronic Disease, Nutrition, Metabolism, Hard Tech
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Aug 2025 $14M $138M Highlight Capital · Jiangsu Bailian Zhigao Venture Capital Management · Hongsheng Capital ↗
SERIES BOther financing Feb 2025 $28M $110M Shanghai CICC Capital · Frees Fund · Feng Qiao Capital · Highlight Capital ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Methuselah Medical Technology website traffic

Latest recorded traffic for Methuselah Medical Technology is 170 monthly website visits, down 63% over the last three months. Methuselah Medical Technology's team grew 9.1% over the past year.

Latest monthly visits170 3-month web change-63% 1-year team growth+9.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Methuselah Medical Technology in its local ecosystem

Live from Dealroom

The Methuselah Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

  • Frees Fund
  • Jinding Capital
  • Shanghai CICC Capital
  • Highlight Capital
  • Feng Qiao Capital
  • Jiangsu Bailian Zhigao Venture Capital Management
  • Hongsheng Capital
Employees 12 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Methuselah Medical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Methuselah Medical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.